These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10233380)

  • 1. Leucocyte alkaline phosphatase identifies terminally differentiated normal neutrophils and its lack in chronic myelogenous leukaemia is not dependent on p210 tyrosine kinase activity.
    Dotti G; Garattini E; Borleri G; Masuhara K; Spinelli O; Barbui T; Rambaldi A
    Br J Haematol; 1999 Apr; 105(1):163-72. PubMed ID: 10233380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
    Lee J; Kim Y; Lim J; Kim M; Han K
    Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of neutrophil alkaline phosphatase gene expression by granulocyte colony-stimulating factor in chronic myelogenous leukemia.
    Tsushita K; Hotta T; Ichikawa A; Murate T; Saito H
    Int J Hematol; 1993 Jan; 57(1):45-52. PubMed ID: 7682859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of leukocyte alkaline phosphatase gene in normal and leukemic cells: regulation of the transcript by granulocyte colony-stimulating factor.
    Rambaldi A; Terao M; Bettoni S; Tini ML; Bassan R; Barbui T; Garattini E
    Blood; 1990 Dec; 76(12):2565-71. PubMed ID: 1702329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Granulocyte alkaline phosphatase activity in the chronic phase and blastic crisis of chronic myeloid leukemia. Sequential study of 43 patients].
    Bosch F; Cervantes F; Rozman M; Terol MJ; Montserrat E; Rozman C
    Sangre (Barc); 1992 Aug; 37(4):245-7. PubMed ID: 1514136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometry of leucocyte alkaline phosphatase in normal and pathologic leucocytes.
    Rambaldi A; Masuhara K; Borleri GM; Amaru R; Giannì M; Terao M; Barbui T; Garattini E
    Br J Haematol; 1997 Mar; 96(4):815-22. PubMed ID: 9074426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid and granulocyte colony-stimulating factor synergistically induce leukocyte alkaline phosphatase in acute promyelocytic leukemia cells.
    Gianní M; Terao M; Zanotta S; Barbui T; Rambaldi A; Garattini E
    Blood; 1994 Apr; 83(7):1909-21. PubMed ID: 7511442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
    Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
    Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocyte alkaline phosphatase activity and peripheral changes of granulocyte following administration of granulocyte colony-stimulating factor.
    Charuruks N; Krailadsiri P; Voravud N
    J Med Assoc Thai; 1996 Dec; 79(12):801-7. PubMed ID: 9071085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMX tyrosine kinase gene is expressed in granulocytes and myeloid leukaemias.
    Kaukonen J; Lahtinen I; Laine S; Alitalo K; Palotie A
    Br J Haematol; 1996 Sep; 94(3):455-60. PubMed ID: 8790141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine kinases but not cAMP-dependent protein kinase mediate the induction of leukocyte alkaline phosphatase by granulocyte-colony-stimulating factor and retinoic acid in acute promyelocytic leukemia cells.
    Gianni M; Li Calzi M; Terao M; Rambaldi A; Garattini E
    Biochem Biophys Res Commun; 1995 Mar; 208(2):846-54. PubMed ID: 7535055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells.
    Andreu EJ; Lledó E; Poch E; Ivorra C; Albero MP; Martínez-Climent JA; Montiel-Duarte C; Rifón J; Pérez-Calvo J; Arbona C; Prósper F; Pérez-Roger I
    Cancer Res; 2005 Apr; 65(8):3264-72. PubMed ID: 15833859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic myelogenous leukemia (CML) associated with granulocyte colony-stimulating factor (G-CSF)-producing mesothelioma.
    Masuda Y; Kizaki M; Ueno H; Mori S; Takayama N; Muto A; Matsushita H; Ikeda E; Kawai Y; Ikeda Y
    Leukemia; 1995 Sep; 9(9):1591-4. PubMed ID: 7544855
    [No Abstract]   [Full Text] [Related]  

  • 14. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
    Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
    Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in treated patients with chronic myelogenous leukemia in chronic phase.
    Balleari E; Bason C; Visani G; Gobbi M; Ottaviani E; Ghio R
    Haematologica; 1994; 79(1):7-12. PubMed ID: 15378942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the expression of alkaline phosphatase mRNA in chronic myelogenous leukemia and paroxysmal nocturnal hemoglobinuria polymorphonuclear leukocytes.
    Rambaldi A; Terao M; Bettoni S; Bassan R; Battista R; Barbui T; Garattini E
    Blood; 1989 Apr; 73(5):1113-5. PubMed ID: 2930836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.
    Brusa G; Benvenuti M; Mazzacurati L; Mancini M; Pattacini L; Martinelli G; Barbieri E; Greenberger JS; Baccarani M; Santucci MA
    Haematologica; 2003 Jun; 88(6):622-30. PubMed ID: 12801837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of G-CSF on the proliferation and differentiation of bcr/abl(+)-CD34+ cells from CML patients].
    Li CY; Meng FY; Sun QX; Fu YB; Jiang QL; Yi ZS; Song LL
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):762-5. PubMed ID: 18457269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Special Education.
    Kozutsumi H
    Oncologist; 1996; 1(1 & 2):116-118. PubMed ID: 10387976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct relation between BCR-ABL tyrosine kinase activity and cyclin D2 expression in lymphoblasts.
    Deininger MW; Vieira SA; Parada Y; Banerji L; Lam EW; Peters G; Mahon FX; Köhler T; Goldman JM; Melo JV
    Cancer Res; 2001 Nov; 61(21):8005-13. PubMed ID: 11691826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.